ArticleJournal of ovarian research2026
Perivitelline space volume and embryonic outcomes in conventional IVF: a single-center retrospective study with mixed-effects model analysis.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo investigate the effect of oocyte perivitelline space volume on embryonic outcomes in conventional in vitro fertilization (IVF) cycles, and to provide an objective morphological quantitative index for evaluating oocyte quality.
methodsA retrospective analysis was conducted on 950 metaphase Ⅱ (MⅡ) oocytes from 110 conventional IVF cycles in the Reproductive Medicine Center of Wenzhou People's Hospital from January to December 2022. PVSV was measured by an image analysis system, and the oocytes were divided into four quartile groups (Q1: <25%, Q2: 25%-50%, Q3: 50%-75%, Q4: >75%) due to the non-normal distribution of PVSV data. The fertilization rate, normal fertilization rate, day-3 (D3) high-quality embryo rate, blastocyst formation rate and high-quality blastocyst rate were compared among the four groups. Mixed-effects models were applied to adjust for confounding factors and intra-patient clustering effects, and to analyze the correlation between PVSV and embryonic outcomes.
resultsPVSV presented a slight right-skewed non-normal distribution, and 90.91% of the cycles contained oocytes from two or more quartile groups. No significant differences were found in fertilization rate and normal fertilization rate among the four groups (P > 0.05). The D3 high-quality embryo rate increased progressively with the elevation of PVSV, while the blastocyst formation rate and high-quality blastocyst rate peaked in Q2 and Q3 groups and decreased significantly in Q1 and Q4 groups (P < 0.05). Mixed-effects models confirmed a significant inverted U-shaped nonlinear correlation between PVSV and the above embryonic developmental indicators, and PVSV was an independent predictor of the in vitro developmental potential of post-fertilization embryos, with the optimal PVSV values clustering around the 3rd-4th deciles (corresponding to Q2-Q3).
conclusionPVSV can serve as an objective and quantitative auxiliary indicator for laboratory-level oocyte quality evaluation in conventional IVF cycles, providing a reference for in vitro oocyte and embryo screening. This study only includes laboratory embryology outcomes and does not provide clinically meaningful outcomes such as implantation, clinical pregnancy, miscarriage, or live birth. Due to the limitations of single-center retrospective design and exclusive focus on in vitro laboratory outcomes, the clinical application value of PVSV, including its correlation with in vivo implantation, clinical pregnancy and live birth outcomes, needs to be further verified by multicenter prospective studies with comprehensive clinical follow-up data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.